| Clinical use of dendritic cells for cancer therapy S Anguille, EL Smits, E Lion, VF van Tendeloo, ZN Berneman The lancet oncology 15 (7), e257-e267, 2014 | 776 | 2014 |
| Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid … VFI Van Tendeloo, P Ponsaerts, F Lardon, G Nijs, M Lenjou, ... Blood, The Journal of the American Society of Hematology 98 (1), 49-56, 2001 | 668 | 2001 |
| Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination VF Van Tendeloo, A Van de Velde, A Van Driessche, N Cools, S Anguille, ... Proceedings of the National Academy of Sciences 107 (31), 13824-13829, 2010 | 471 | 2010 |
| Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells N Cools, P Ponsaerts, VFI Van Tendeloo, ZN Berneman Journal of Leucocyte Biology 82 (6), 1365-1374, 2007 | 382 | 2007 |
| CD56 in the immune system: more than a marker for cytotoxicity? HH Van Acker, A Capsomidis, EL Smits, VF Van Tendeloo Frontiers in immunology 8, 892, 2017 | 363 | 2017 |
| Regulatory T cells and human disease N Cools, P Ponsaerts, VFI Van Tendeloo, ZN Berneman Journal of Immunology Research 2007 (1), 089195, 2007 | 313 | 2007 |
| The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy ELJM Smits, P Ponsaerts, ZN Berneman, VFI Van Tendeloo The oncologist 13 (8), 859-875, 2008 | 272 | 2008 |
| mRNA-based gene transfer as a tool for gene and cell therapy. VF Van Tendeloo, P Ponsaerts, ZN Berneman Current opinion in molecular therapeutics 9 (5), 423-431, 2007 | 239 | 2007 |
| Cancer immunotherapy using RNA-loaded dendritic cells P Ponsaerts, VFI Van Tendeloo, ZN Berneman Clinical & Experimental Immunology 134 (3), 378-384, 2003 | 218 | 2003 |
| Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia S Anguille, VF Van Tendeloo, ZN Berneman Leukemia 26 (10), 2186-2196, 2012 | 215 | 2012 |
| Bisphosphonates for cancer treatment: mechanisms of action and lessons from clinical trials HH Van Acker, S Anguille, Y Willemen, EL Smits, VF Van Tendeloo Pharmacology & therapeutics 158, 24-40, 2016 | 212 | 2016 |
| Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia S Anguille, AL Van de Velde, EL Smits, VF Van Tendeloo, G Juliusson, ... Blood, The Journal of the American Society of Hematology 130 (15), 1713-1721, 2017 | 209 | 2017 |
| A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile EMF Van Craenenbroeck, CJ Vrints, SE Haine, K Vermeulen, I Goovaerts, ... Journal of applied physiology 104 (4), 1006-1013, 2008 | 204 | 2008 |
| Dendritic cells as pharmacological tools for cancer immunotherapy S Anguille, EL Smits, C Bryant, HH Van Acker, H Goossens, E Lion, ... Pharmacological reviews 67 (4), 731-753, 2015 | 179 | 2015 |
| Natural killer cell immune escape in acute myeloid leukemia E Lion, Y Willemen, ZN Berneman, VFI Van Tendeloo, ELJ Smits Leukemia 26 (9), 2019-2026, 2012 | 172 | 2012 |
| Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation and storage alter with the phenotype studied SH Van Ierssel, EM Van Craenenbroeck, VM Conraads, VF Van Tendeloo, ... Thrombosis research 125 (4), 332-339, 2010 | 151 | 2010 |
| Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor-but not monocyte-derived … VFI Van Tendeloo, HW Snoeck, F Lardon, GLEE Vanham, G Nijs, ... Gene Therapy 5 (5), 700-707, 1998 | 149 | 1998 |
| RNA-based gene transfer for adult stem cells and T cells E Smits, P Ponsaerts, M Lenjou, G Nijs, DR Van Bockstaele, ... Leukemia 18 (11), 1898-1902, 2004 | 147 | 2004 |
| Efficient genetic modification of murine dendritic cells by electroporation with mRNA S Van Meirvenne, L Straetman, C Heirman, M Dullaers, C De Greef, ... Cancer gene therapy 9 (9), 787-797, 2002 | 144 | 2002 |
| Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation … A Van Driessche, ALR Van de Velde, G Nijs, T Braeckman, B Stein, ... Cytotherapy 11 (5), 653-668, 2009 | 140 | 2009 |
